TOPLINE Public vaccine company Novavax announced today that it will receive up to $388 million from the Coalition for Epidemic Preparedness (CEPI) to continue development and manufacturing of its COVID-19 vaccine candidate.
SUBSCRIBE
Biohealth Innovation
Founding Member of
